🇺🇸 FDA
Patent

US 9913910

Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

granted A61KA61K31/439A61K31/445

Quick answer

US patent 9913910 (Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron) held by Heron Therapeutics, Inc. expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Heron Therapeutics, Inc.
Grant date
Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/439, A61K31/445, A61K31/573, A61K31/765